These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11711410)

  • 21. Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
    Potthoff A; Deterding K; Trautwein C; Rifai K; Manns MP; Wedemeyer H
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):906-9. PubMed ID: 17873617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ribavirin in combination with interferon alpha-2b in the treatment of chronic hepatitis C].
    Hillon P
    Presse Med; 2001 Feb; 30(7):335-6. PubMed ID: 11262810
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antiviral therapy of chronic viral hepatitis].
    Trautwein C; Manns MP
    Internist (Berl); 2001 Jun; 42(6):913-23. PubMed ID: 11449639
    [No Abstract]   [Full Text] [Related]  

  • 24. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.
    Soza A; Hoofnagle JH
    Hepatology; 2003 Jul; 38(1):267. PubMed ID: 12830010
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of chronic viral hepatitis.
    Main J; McCarron B; Thomas HC
    Antivir Chem Chemother; 1998 Nov; 9(6):449-60. PubMed ID: 9865383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence and clinical course in HBV and HCV dual chronic infection].
    Tamori A; Nishiguchi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):667-70. PubMed ID: 15359882
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].
    Fontaine H; Pol S
    Gastroenterol Clin Biol; 1999 Apr; 23(4):541-4. PubMed ID: 10416124
    [No Abstract]   [Full Text] [Related]  

  • 28. Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.
    Flink HJ; Buster EH; Merican I; Nevens F; Kitis G; Cianciara J; de Vries RA; Hansen BE; Schalm SW; Janssen HL
    Gut; 2007 Oct; 56(10):1485-6. PubMed ID: 17872587
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of Interferon-α and Combined Interferon-α with Lamivudine Treatment on Anthropometric Measurements in Children with Chronic Hepatitis B.
    Urganci N; Kalyoncu D; Erdem Eralp E
    Ann Nutr Metab; 2017; 71(1-2):8-9. PubMed ID: 28624823
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination therapy with interferon-alpha and ribavirin as immunomodulators in patients with chronic hepatitis C.
    Horiike N; Onji M
    J Gastroenterol; 2003; 38(3):302-4. PubMed ID: 12693384
    [No Abstract]   [Full Text] [Related]  

  • 31. Peginterferon and lamivudine for hepatitis B.
    Assy NN; Hussein O
    N Engl J Med; 2004 Dec; 351(27):2879; author reply 2879. PubMed ID: 15625344
    [No Abstract]   [Full Text] [Related]  

  • 32. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
    [No Abstract]   [Full Text] [Related]  

  • 33. [Peginterferon alpha combined with ribavirin for the treatment of chronic hepatitis C].
    Xu Y; Wang JB
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):415-6. PubMed ID: 22053369
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
    Fujita N; Sugimoto R; Urawa N; Araki J; Mifuji R; Yamamoto M; Horiike S; Tanaka H; Iwasa M; Kobayashi Y; Adachi Y; Kaito M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1886-93. PubMed ID: 17914965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Opinion on interferon-ribavirin association in the primary treatment of chronic hepatitis C].
    Bergmann JF
    Presse Med; 1999 Jan; 28(2):77-8. PubMed ID: 9989300
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of chronic hepatitis B with integrative medicine].
    Ye YA
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jan; 28(1):8-9. PubMed ID: 18418958
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of chronic hepatitis C--ribavirin plus interferon versus interferon. An analysis of a systematic Cochrane review].
    Laursen AL; Vilstrup H
    Ugeskr Laeger; 2006 Nov; 168(48):4209-12. PubMed ID: 17147946
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
    Song K; Rajvanshi P
    N Engl J Med; 2005 Oct; 353(15):1630-1; author reply 1630-1. PubMed ID: 16221792
    [No Abstract]   [Full Text] [Related]  

  • 39. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.
    Mutimer D; Dowling D; Cane P; Ratcliffe D; Tang H; O'Donnell K; Shaw J; Elias E; Pillay D
    Antivir Ther; 2000 Dec; 5(4):273-7. PubMed ID: 11142622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
    MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.